Filing Details
- Accession Number:
- 0001161697-22-000456
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-15 17:01:05
- Reporting Period:
- 2022-09-13
- Accepted Time:
- 2022-09-15 17:01:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402535 | Steve Miller | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Disposition | 2022-09-13 | 25,000 | $17.01 | 736,724 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 Per Share | Disposition | 2022-09-13 | 7,933 | $17.11 | 728,791 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 Per Share | Disposition | 2022-09-13 | 75,000 | $16.85 | 653,791 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Dr. Miller remains an officer of the Company.